Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ketamine Health Centers is a leading provider of mental health and chronic pain treatments, specializing in medically supervised ketamine infusion therapy. Founded in 2016 and headquartered in Florida, the company operates a network of clinics that offer a holistic approach to treating treatment-resistant conditions such as depression, PTSD, and fibromyalgia. In 2022, the company was acquired by Irwin Naturals as a cornerstone of its 'Irwin Naturals Emergence' national clinic roll-up strategy. The centers provide IV ketamine infusions, esketamine (Spravato) nasal spray, and ketamine-assisted psychotherapy (KAP) to help patients achieve long-term relief. With locations across Florida and a partnership in Mexico, Ketamine Health Centers focuses on safety, personalized care, and expanding access to psychedelic-assisted wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ketamine Health Centers.